RNA
Atrium Therapeutics, Inc.
Nasdaq: RNA · San Diego, CA · Healthcare
$13.53-0.77 (-5.38%)Closed
Market Cap—
Cash—most recent
Runway—
P/E (TTM)—
52-Wk Range$12.32 – $16.54
Avg Volume1.0M3-month
Price & Trading Activity
Daily close with catalyst overlays and trading volume
$13.53-8.3%
Pipeline
Drug candidates sponsored by Atrium Therapeutics · ClinicalTrials.gov
No trials found for this sponsor.
Valuation
Risk-adjusted NPV
Loading pipeline…
Peer comparison
Cohort check
No peer cohort defined for RNA. Cohorts currently cover gene editing, mRNA, rare-disease gene therapy, and large-cap biotech — more coming soon.